Bosse, T <br/><br/>
L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Oct 2014 
 - 2602-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0852 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2014.07.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Combined Modality Therapy<br/>Endometrial Neoplasms--metabolism<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Recurrence, Local--diagnosis<br/>Neoplasm Staging<br/>Neural Cell Adhesion Molecule L1--metabolism<br/>Postoperative Period<br/>Predictive Value of Tests<br/>Prognosis<br/>Radiotherapy--methods<br/>Randomized Controlled Trials as Topic<br/>Risk Factors<br/>Treatment Outcome